BOA is at the top of the holdings list of the 30M shares short on Ariad from $2? No wonder BOA's Rachel McMinn's AP26113 valuation is ZERO and her ARIA target price was/is $2/$3. She may lose her job with BOA. And no wonder she was unprofessional and pathetic at the latest Ariad CC as observed by biotech_researcher.
Just curious if anyone knows/understands what these swaps are. I was trying to figure out who would possibly hold 30M shares short on Araid from $2. I tried to look at the holdings of the ProShares biotechnology ultrashort ETF, ticker symbol 'BIS'. At the top of the holdings list is a Bank of America Nasdaq biotechnology index swap. I had also noticed the 2M shares were shorted on December 9th, and then I noticed that large quantities of almost every biotech stock I watch were shorted on December 9th, so I thought it must be the result of a hedge fund activity of some kind. Just curious, anyone know what's happening with this?
We Ariad true longs like Jesspro and Amp and myself were said to be in denial a while a go. Aren't Rachel McMinn and the shorts in denial now? LOL!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.